It agreed to pay £470m and said it had ordered a subsidiary to plead guilty in a trial over what prosecutors described as a ‘truly shameful scheme’ that put profits before the health of patients.
MARKET REPORT: Indivior shares soar as scandal ends
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]